Family history another strong risk factor is family


Family history-Another strong risk factor is family history. Those who have a parent, brother or
sister with Alzheimer’s are more likely to develop the disease. The risk increases if more than
one family member has the illness. When diseases tend to run in families, either heredity
(genetics), environmental factors, or both, may play a role (. Alzheimer’s Association, 2019).

Genetics-Scientists know genes are involved in Alzheimer’s. Two categories of genes influence
whether a person develops a disease: risk genes and deterministic genes. Alzheimer's genes
have been found in both categories. It is estimated that less than 1 percent of Alzheimer’s cases
are caused by deterministic genes (genes that cause a disease, rather than increase the risk of
developing a disease. (. Alzheimer’s Association, 2019).

( Bekris, Yu, Bird, & Tsuang, 2010)
CONTRIBUTING FACTORS

The diagnosis of AD is based on clinical history, neurological examination, and neuropsychological tests.
The
methods used are to rule out other diagnoses.
•
Mental Status Exam
•
Neuropsychological Testing
•
Blood Tests
•
Electroencephalogram (EEG)
•
Computed Tomography Scan (CT)
•
Magnetic Resonance Imaging (MRI)
•
Genetic Testing
•
The only way to confirm the disease is through autopsy (Alzheimer's Association, 2018).
(Kumar, Singh, & Ekavali, 2015)
Alzheimer’s Association, 2019).
Diagnostic Methods


Namenda- treats moderate to
severe Alzheimer’s disease.
Primary goal is to decrease
symptoms, which could allow
some people to maintain certain
daily functions a little longer than
they would without the
medication.

These drugs may help reduce some
symptoms and help control some
behavioral symptoms. The
medications are Razadyne
(galantamine), Exelon
(rivastigmine), and Aricept,
donepezil.

(Alzheimer’s Association, 2019)
Treatment Options:


Coralie, Barbe., Isabelle, Morrone, Wolak-Thierry, Aurore., Moustapha, Drame, Damien Jolly, &
Novella, J.,(2015).Impact of Functional alterations on quality of life in patients with Alzheimer’s
disease. 571-576.


Bekris, L. M., Yu, C. E., Bird, T. D., & Tsuang, D. W. (2010). Genetics of Alzheimer disease. Journal
of geriatric psychiatry and neurology, 23(4), 213–227. doi:10.1177/0891988710383571


Alzheimer's Disease & Dementia | Alzheimer's Association. (2019). Retrieved from
disease_what_is_alzheimers.asp


Arcangelo, V. P., Peterson, A. M., Wilbur, V. F., & Reinhold, J. A. (2017). Pharmacotherapeutics for